Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysis-Reference-Cited by-同舟云学术

Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysis

Published:2022-01-20 Issue:3 Volume:39 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Kayabasi Cagla^ORCID,Caner Ayse^ORCID,Yilmaz Susluer Sunde,Balci Okcanoglu Tugce,Ozmen Yelken Besra,Asik Aycan,Mutlu Zeynep,Caliskan Kurt Cansu,Goker Bagca Bakiye,Biray Avci Cigir,Sahin Fahri,Saydam Guray,Gunduz Cumhur

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-021-01629-0.pdf

Reference34 articles.

1. Sawyers CL. Chronic myeloid leukemia. N Engl J Med. 1999;340(17):1330–40. https://doi.org/10.1056/NEJM199904293401706.

2. Melo JV, Barnes DJ. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer. 2007;7(6):441–53. https://doi.org/10.1038/nrc2147.

3. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, et al. Efficacy and safety of a specific inhibitor of the bcr-abl tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001;344(14):1031–7. https://doi.org/10.1056/NEJM200104053441401.

4. Garg RJ, Kantarjian H, O’Brien S, Quintas-Cardama A, Faderl S, et al. The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up. Blood. 2009;114(20):4361–8. https://doi.org/10.1182/blood-2009-05-221531.

5. Montero JC, Seoane S, Ocana A, Pandiella A. Inhibition of src family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors. Clin Cancer Res. 2011;17(17):5546–52. https://doi.org/10.1158/1078-0432.CCR-10-2616.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The lncRNA expression profile signature of leukemia stem cells is altered upon PI3K/mTOR inhibition: an in vitro and in silico study;Nucleosides, Nucleotides & Nucleic Acids;2023-07-20

2. Synergistic cytotoxicity effect of the combination of chitosan nanoencapsulated imatinib mesylate and quercetin in BCR-ABL positive K562 cells;IRAN J BASIC MED SCI;2023